Graphical Abstract Similar content being viewed by others Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD), with a steady upward trend in prevalence estimates from 25.3% in 19902006 to 38.2% in 20162019 [1], has become a leading cause of chronic liver disease worldwide [2,3,4], increasing the risk of both hepatic and extrahepatic complications, such as cardiovascular and chronic kidney diseases [5, 6]
GLP-1 receptor agonists work through several mechanisms: they enhance insulin secretion when blood glucose levels are elevated, suppress glucagon release (which reduces glucose production by the liver), slow gastric emptying, and promote satiety through effects on appetite centres in the brain
Every hair on your head goes through three phases: Anagen (Growth Phase): Lasts 2-7 years
You can read more about natural GLP-1 support strategies that focus on diet and daily habits
Its unique architecture allows for a coordinated metabolic response that is frequently studied for its potential to surpass the efficacy of dual agonists like Tirzepatide